19 results
DEFR14A
ARCT
Arcturus Therapeutics Holdings Inc
12 May 22
Revised proxy
5:00pm
from the University of California at Berkeley.
Director Independence
The listing rules of Nasdaq require us to maintain a Board comprised … and compensation committee members must also satisfy the independence criteria set forth in Rule 10A-3 and Rule 10C-1, respectively, under the Securities
8-K
EX-1.1
rbtjfn4 gi6nd25to6i1
8 Dec 20
Arcturus Therapeutics Announces Pricing of $150 Million Public Offering of Common Stock
9:01am
8-K
EX-1.1
mq85hrq 9vs3is
29 Jul 20
Arcturus Therapeutics Announces Pricing of $173.0 Million Public Offering of Common Stock
6:02am
8-K
EX-1.1
d8gvqra y2
17 Apr 20
Entry into a Material Definitive Agreement
6:06am
8-K
EX-10.1
22rsqa
27 Mar 20
Entry into a Material Definitive Agreement
5:20pm
10-K
ltphp4qk3jri
16 Mar 20
Annual report
11:09am
DEF 14A
krttn55k
1 Oct 19
Definitive proxy
6:07am
424B3
be6x0 53kl
12 Apr 19
Prospectus supplement
4:39pm
S-4/A
xk0c2
11 Apr 19
Registration of securities issued in business combination transactions (amended)
5:26pm
S-4
y0s3g1k 5g6wo
15 Mar 19
Registration of securities issued in business combination transactions
9:35pm
- Prev
- 1
- Next